Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 5/21/2024
NEW PRODUCT: Ranopto for neovascular age-related macular degeneration and more
Get the info you need on this new product, part of our drug news roundup for May. - 5/21/2024
NEW PRODUCT: Jamteki for chronic moderate to severe plaque psoriasis, active psoriatic arthritis
Get the info you need on this new product, part of our drug news roundup for May. - 5/21/2024
NEW PRODUCT: Epidiolex for adjunctive treatment of seizures
Get the info you need on this new product, part of our drug news roundup for May. - 5/16/2024
Updated Canadian guidelines for management of depression in adults
Revised CANMAT guidelines outline patient assessment, selection of evidence-based treatments, prevention of recurrence and strategies for managing inadequate response. - 5/12/2024
POP QUIZ: Hypoglycemia in adults with diabetes
Can you tell which of these statements is false? - 5/9/2024
Best smoking cessation strategy after failure of varenicline or combined nicotine replacement therapy
Study provides healthcare providers with guidance on the best rescue strategies for nonabstinent patients following an initial six-week quit attempt. - 5/6/2024
Antipsychotics associated with a wide range of adverse outcomes in dementia
Risks of a broad range of adverse outcomes need to be considered before prescribing antipsychotic drugs for people with dementia. - 5/1/2024
ASA should not be recommended as an adjuvant treatment for breast cancer
A U.S. and Canada study shows that ASA 300 mg daily does not improve risk of breast cancer recurrence or survival in individuals with high-risk nonmetastatic breast cancer. - 4/29/2024
Septa Pharma receives approval to import aminophylline injection during shortage
Aminophylline 25 mg/mL injection will be available from Septa Pharma under Exceptional Import Approval by Health Canada to fulfill the Tier 3 shortage.
